The global CRO where clinical trials run on time
Finding a CRO to deliver your pivotal Phase 2 & 3 clinical trials on time and on budget isn’t easy. Choose the CRO you can trust.
Therapeutic areas
Oncology
Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer and other Oncology indications.
Hematology
Multiple Myeloma, Lymphomas, Leukemias and other oncohematological indications.
Rare Diseases
Hemophilia A & B, Von Willebrand Disease, Thrombocytopenia, Polycythemia Vera, Paroxysmal Nocturnal Hemoglobinuria (PNH).
Be ahead of your time.
Our mission is to be the best CRO in the world as measured by our employees, clients, investigators, and vendors.
Our teams work tirelessly to ensure that we deliver on time and on budget. You will always know what’s going on with your study when you work with PSI. That means not losing control over study timelines and budgets.
The PSI Advantage
PSI On Point
PSI has been exceedingly professional and is respected by our site as a great collaborator.
Anthony W. Tolcher, MD, FRCP, FACP
Delivered 24 phase II and III IBD studies